National Health Council, Washington, DC, USA.
Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD, USA.
Patient. 2022 Nov;15(6):619-627. doi: 10.1007/s40271-022-00583-x. Epub 2022 Jun 2.
A quote attributed to Mark Twain states, "What gets us into trouble is not what we don't know. It's what we know for sure that just ain't so." The growing focus on patient centricity has revealed a misalignment between what patients report as important to them about their disease and/or treatment, and the data collected in research and care. Decisions across healthcare are made using an evidence base most stakeholders acknowledge is inadequate. Patients might report that what is important to them are everyday life impacts, concepts that can be very different from the more typical clinical outcomes we often track. In this paper, we encourage expanding current thinking to all "impacts," not only health outcomes, but also the other equally (and sometimes more important) concerns patients report as important to them. We propose that a patient-centered core impact set be developed for each disease or condition of interest, and/or subpopulation of patients. A patient-centered core impact set begins with gathering from patients and caregivers an inventory of all impacts disease and treatments have on a patient's (and carers' and families') life. Then, through a formal prioritization process, a core set of impacts is derived, inclusive of but extending beyond relevant health outcomes. We offer several recommendations on how to move the goal of a patient-centered core impact set forward through collaboration, leadership, and establishment of a patient-centered core impact set development blueprint with supporting tools.
马克·吐温有句名言:“真正让我们陷入困境的,不是我们不知道的东西,而是我们坚信不疑、但实际上并不正确的东西。”随着人们越来越关注以患者为中心,患者所报告的对其疾病和/或治疗至关重要的内容与在研究和护理中收集的数据之间出现了错位。医疗保健领域的各种决策都是基于大多数利益相关者认为不充分的证据基础做出的。患者可能会报告说,对他们来说重要的是日常生活的影响,这些概念与我们通常跟踪的更典型的临床结果可能非常不同。在本文中,我们鼓励将当前的思维扩展到所有“影响”,不仅是健康结果,还包括患者报告的对他们同样重要(有时甚至更重要)的其他问题。我们建议为每个感兴趣的疾病或病症,以及/或患者的亚人群,开发一个以患者为中心的核心影响集。以患者为中心的核心影响集从收集患者和护理人员关于疾病和治疗对患者(以及护理人员和家属)生活的所有影响开始。然后,通过一个正式的优先级制定过程,得出一组核心影响,其中包括但不限于相关的健康结果。我们提出了一些建议,关于如何通过合作、领导力以及建立一个具有支持工具的以患者为中心的核心影响集开发蓝图来推动以患者为中心的核心影响集的目标。